Cargando…
Serum HBV RNA: a promising biomarker for blood product safety screening and enhanced diagnostic efficiency in chronic hepatitis B virus infection
Autores principales: | Yu, Sulan, Guo, Yanjuan, Zhang, Chunxiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501715/ https://www.ncbi.nlm.nih.gov/pubmed/37719720 http://dx.doi.org/10.3389/fpubh.2023.1248878 |
Ejemplares similares
-
A Study of Knowledge, Experience, and Beliefs About Hepatitis B Virus (HBV) Infection in South Western Uganda
por: Mugisha, Joseph, et al.
Publicado: (2019) -
Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China
por: Li, Si-Yue, et al.
Publicado: (2011) -
The COVID-19 Diagnostic Technology Landscape: Efficient Data Sharing Drives Diagnostic Development
por: Aguiar, Eric R. G. R., et al.
Publicado: (2020) -
Peripheral blood cytokines as potential diagnostic biomarkers of suicidal ideation in patients with first-episode drug-naïve major depressive disorder
por: Xu, Yayun, et al.
Publicado: (2022) -
Management of in- and out-of-hospital screening for hepatitis C
por: Zhou, Jing, et al.
Publicado: (2023)